Pharmacy Medical News about Epilepsy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
Neuropsychiatric Disease and Treatment, 11/04/09

Stafstrom CE – Rufinamide is a promising adjunctive therapy for Lennox–Gastaut syndrome, an intractable childhood epilepsy. To ensure its optimal effectiveness, clinicians must be familiar with the medication’s clinical response profile and potential for adverse effects.

<< Previous
Treatment of Premature Ejaculation in the Asia-Pacific Region:...

Next >>
Efficacy of different doses of aspirin in decreasing blood levels...

Current and future treatment of epilepsy
The Internet Journal of Neurology, 11/03/09 Relevance Score: 91%

“It shouldn’t be something that's evil, it should be talked about”: A phenomenological approach to epilepsy and stigma
Seizure - European Journal of Epilepsy, 10/15/09 Relevance Score: 89%

Interictal EEG spikes identify the region of electrographic seizure onset in some, but not all, pediatric epilepsy patients
Epilepsia, 10/01/09 Relevance Score: 89%

Medically intractable epilepsy in Sturge-Weber syndrome is associated with cortical malformation: Implications for surgical therapy
Epilepsia, 10/01/09 Relevance Score: 89%

Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: A case–control study
Epilepsia, 10/21/09 Relevance Score: 88%